Anti-inflammatory and carbonic anhydrase restoring actions of yam powder (Dioscorea spp) contribute to the prevention of cysteamine-induced duodenal ulcer in a rat model

Nutr Res. 2013 Aug;33(8):677-85. doi: 10.1016/j.nutres.2013.05.019. Epub 2013 Jul 8.

Abstract

Increased acid output, accompanied with a defective defense system, is considered a fundamental pathogenesis of duodenal ulcer (DU). However, relapse of DU occurs despite proton pump inhibitors and H2 receptor antagonists, hence imposing the enforcement of the defense system. Dried powder of the yam tuber (Dioscorea spp) has been used in traditional folk medicine as a nutritional fortification. We hypothesized that dried-yam powder would prevent DU through improvement of anti-inflammatory actions and carbonic anhydrase (CA) activity. Therefore, we investigated the preventive effects of dried-yam powder against the cysteamine-induced DU and elucidated the underlying mechanisms. Duodenal ulcers were induced in Sprague-Dawley rats by intragastric administration of 500 mg/kg cysteamine-HCl. The dried-yam powder was used as a pretreatment before the cysteamine-HCl. The number and size of DU were measured. The expressions of inflammation mediators were checked in duodenal tissues, and the expressions of CAs and malondialdehyde levels were also examined. Cysteamine provoked perforated DU, whereas dried-yam powder significantly prevented DU as much as pantoprazole and significantly reduced the incidence of perforation. The messenger RNA expressions of cyclooxygenase-2 and inducible nitric oxide synthase were remarkably decreased in the yam group compared with the cysteamine group, and the serum levels of proinflammatory cytokines including interleukin-1β, interleukin-6, and tumor necrosis factor were significantly attenuated in the yam group. Cysteamine significantly decreased the expression of CAs, whereas yam treatment significantly preserved the expressions of CA IX, XII, and XIV. In conclusion, dried-yam powder exerts a significant protective effect against cysteamine-induced DU by lowering the activity of inflammatory cytokines and free radicals and restoring the activity of CAs, except in CA IV.

Keywords: CA; COX-2; Carbonic anhydrase; Cysteamine; DBS; DU; Duodenal ulcer; IL; MCP; MDA; Rat; TNF-α; Yam; carbonic anhydrase; cyclooxygenase-2; duodenal bicarbonate secretion; duodenal ulcer; iNOS; inducible nitric oxide synthase; interleukin; mRNA; malondialdyhyde; messenger RNA; monocyte chemotactic protein; tumor necrosis factor α.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • 2-Pyridinylmethylsulfinylbenzimidazoles / therapeutic use
  • Animals
  • Anti-Inflammatory Agents / pharmacology
  • Anti-Inflammatory Agents / therapeutic use*
  • Anti-Ulcer Agents / pharmacology
  • Anti-Ulcer Agents / therapeutic use*
  • Carbonic Anhydrases / metabolism*
  • Cyclooxygenase 2 / genetics
  • Cyclooxygenase 2 / metabolism
  • Cyclooxygenase 2 Inhibitors / pharmacology
  • Cyclooxygenase 2 Inhibitors / therapeutic use
  • Cysteamine
  • Cytokines / blood
  • Dioscorea*
  • Disease Models, Animal
  • Duodenal Ulcer / chemically induced
  • Duodenal Ulcer / drug therapy*
  • Duodenal Ulcer / metabolism
  • Inflammation Mediators / metabolism
  • Male
  • Nitric Oxide Synthase Type II / genetics
  • Nitric Oxide Synthase Type II / metabolism
  • Pantoprazole
  • Phytotherapy*
  • Plant Preparations / pharmacology
  • Plant Preparations / therapeutic use*
  • Plant Tubers
  • Powders
  • RNA, Messenger / metabolism
  • Rats
  • Rats, Sprague-Dawley

Substances

  • 2-Pyridinylmethylsulfinylbenzimidazoles
  • Anti-Inflammatory Agents
  • Anti-Ulcer Agents
  • Cyclooxygenase 2 Inhibitors
  • Cytokines
  • Inflammation Mediators
  • Plant Preparations
  • Powders
  • RNA, Messenger
  • Cysteamine
  • Pantoprazole
  • Nitric Oxide Synthase Type II
  • Cyclooxygenase 2
  • Carbonic Anhydrases